Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies. | Transplant Cell Ther | 2022 | 35781099 | PubTator, text mining | PubMed |
| Insight Into Rho Kinase Isoforms in Obesity and Energy Homeostasis. | Front Endocrinol (Lausanne) | 2022 | 35769086 | PubTator, text mining | PubMed |
| Endotoxins Induced ECM-Receptor Interaction Pathway Signal Effect on the Function of MUC2 in Caco2/HT29 Co-Culture Cells. | Front Immunol | 2022 | 35757703 | PubTator, text mining | PubMed |
| A Quantitative Proteomic Approach Explores the Possible Mechanisms by Which the Small Molecule Stemazole Promotes the Survival of Human Neural Stem Cells. | Brain Sci | 2022 | 35741576 | PubTator, text mining | PubMed |
| Human Trabecular Meshwork (HTM) Cells Treated with TGF-β2 or Dexamethasone Respond to Compression Stress in Different Manners. | Biomedicines | 2022 | 35740359 | PubTator, text mining | PubMed |
| Laminin-511 Activates the Human Induced Pluripotent Stem Cell Survival via α6β1 Integrin-Fyn-RhoA-ROCK Signaling. | Stem Cells Dev | 2022 | 35726387 | PubTator, text mining | PubMed |
| ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma. | Oncogene | 2022 | 35725908 | PubTator, text mining | PubMed |
| Identification of genetic polymorphisms in unexplained recurrent spontaneous abortion based on whole exome sequencing. | Ann Transl Med | 2022 | 35722368 | PubTator, text mining | PubMed |
| Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2022 | 35721111 | PubTator, text mining | PubMed |
| Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders. | Cancer Cell Int | 2022 | 35715800 | PubTator, text mining | PubMed |
| Different Aspects of Emetine's Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19. | ACS Pharmacol Transl Sci | 2022 | 35702393 | PubTator, text mining | PubMed |
| Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells. | J Am Heart Assoc | 2022 | 35699166 | PubTator, text mining | PubMed |
| Advances in the Study of Inhaled Formulations for the Treatment of Pulmonary Arterial Hypertension. | Appl Bionics Biomech | 2022 | 35694279 | PubTator, text mining | PubMed |
| Antisense transcription from lentiviral gene targeting linked to an integrated stress response in colorectal cancer cells. | Mol Ther Nucleic Acids | 2022 | 35694213 | PubTator, text mining | PubMed |
| Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study. | Int J Retina Vitreous | 2022 | 35690809 | PubTator, text mining | PubMed |
| ITRAQ-based quantitative proteomic analysis reveals that VPS35 promotes the expression of MCM2-7 genes in HeLa cells. | Sci Rep | 2022 | 35690672 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| A systematic review of translation and experimental studies on internal anal sphincter for fecal incontinence. | Ann Coloproctol | 2022 | 35678021 | PubTator, text mining | PubMed |
| MicroRNA Expression in Circulating Leukocytes and Bioinformatic Analysis of Patients With Moyamoya Disease. | Front Genet | 2022 | 35669195 | PubTator, text mining | PubMed |
| Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases. | Neural Regen Res | 2022 | 35662192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=43